Last week, the journal Science published a paper by Johns Hopkins University cancer geneticist Bert Vogelstein and biostatistician Cristian Tomasetti reporting that two-thirds of all cancers are unavoidable.
Read More
The California Institute for Regenerative Medicine (CIRM), has completely overhauled its process for funding projects to develop stem cell-based treatments and therapies. Beginning January 1, CIRM, which is California's voter-supported, grant- and loan-making agency funding stem cell research, will launch CIRM 2.0 which will shorten the time from application to funding from nearly two years to 120 days.
Read More
0 Comments Click here to read/write comments
Tags: clinical trials, stem cells
